Filing Details

Accession Number:
0001477449-24-000046
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 16:10:16
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 16:10:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC Services-Offices & Clinics Of Doctors Of Medicine (8011) 043705970
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1726419 Stephany Verstraete C/O Teladoc Health, Inc.,
2 Manhattanville Road, Suite 203
Purchase NY 10577
Chief Marketing Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-03-01 4,437 $0.00 47,554 No 4 M Direct
Common Stock Acquisiton 2024-03-01 437 $0.00 47,991 No 4 M Direct
Common Stock Acquisiton 2024-03-01 867 $0.00 48,858 No 4 M Direct
Common Stock Acquisiton 2024-03-01 1,404 $0.00 50,262 No 4 M Direct
Common Stock Acquisiton 2024-03-01 13,021 $0.00 63,283 No 4 M Direct
Common Stock Acquisiton 2024-03-01 1,148 $0.00 64,431 No 4 M Direct
Common Stock Disposition 2024-03-04 7,945 $14.52 56,486 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Stock Units Acquisiton 2024-03-01 13,313 $0.00 13,313 $0.00
Common Stock Performance Stock Units Disposition 2024-03-01 4,437 $0.00 4,437 $0.00
Common Stock Performance Stock Units Disposition 2024-03-01 437 $0.00 437 $0.00
Common Stock Performance Stock Units Disposition 2024-03-01 867 $0.00 867 $0.00
Common Stock Restricted Stock Units Disposition 2024-03-01 1,404 $0.00 1,404 $0.00
Common Stock Restricted Stock Units Disposition 2024-03-01 13,021 $0.00 13,021 $0.00
Common Stock Restricted Stock Units Disposition 2024-03-01 1,148 $0.00 1,148 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,313 No 4 A Direct
8,876 No 4 M Direct
0 No 4 M Direct
0 No 4 M Direct
5,616 No 4 M Direct
26,042 No 4 M Direct
0 No 4 M Direct
Footnotes
  1. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  4. Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
  5. Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
  6. The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  7. On March 1, 2024, the reporting person earned 13,313 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  8. On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
  9. On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
  10. On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  11. On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  12. On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.